Document Detail


Dual-acting angiotensin receptor-neprilysin inhibition.
MedLine Citation:
PMID:  21046489     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Lowering blood pressure by pharmacologic intervention reduces the incidence of cardiovascular events. Nevertheless, despite the widespread availability of effective antihypertensive medications, the vast majority of hypertensive patients worldwide continue to have inadequate blood pressure control. The development of new antihypertensive drugs could contribute to improving the hypertension control rate, and the blockade of new pathophysiologic pathways involved in blood pressure regulation would offer additional benefits. The dual inhibition of the angiotensin II receptor and neprilysin could provide clinical benefits in a range of cardiovascular diseases, including hypertension and heart failure.
Authors:
Julian Segura; Luis M Ruilope
Related Documents :
20619499 - Does antihypertensive drug therapy decrease morbidity or mortality in patients with a h...
18401229 - Implementing effective hypertension quality improvement strategies: barriers and potent...
11447499 - Current concepts in the treatment of hypertension.
22520149 - Regional anaesthesia with sedation protocol to safely debride sacral pressure ulcers.
15989899 - Update on the drug treatment of hypertension in patients with cardiovascular disease.
12400149 - Barriers to blood pressure control in african americans. overcoming obstacles is challe...
22921409 - Anomalous dependence of particle size on supersaturation in the preparation of iron nan...
3395539 - Cardiovascular actions of trimetaphan nitroprusside. comparison with sodium nitroprussi...
20530299 - Target blood pressure for treatment of isolated systolic hypertension in the elderly: v...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current hypertension reports     Volume:  13     ISSN:  1534-3111     ISO Abbreviation:  Curr. Hypertens. Rep.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888982     Medline TA:  Curr Hypertens Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  74-8     Citation Subset:  IM    
Affiliation:
Hypertension Unit, Hospital 12 de Octubre, Av. Córdoba s/n, Madrid, Spain. hta@juliansegura.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The use of a stringent selection system allows the identification of DNA elements that augment gene ...
Next Document:  Is there a link between angiotensin receptor blockers and cancer?